AKLIEF 50 MCG
TRIFAROTENE : 50 MCG · DIN 02494175 · GALDERMA CANADA INC
Health Canada status: MARKETED
What is AKLIEF?
AKLIEF 50 MCG contains TRIFAROTENE : 50 MCG. It is listed in the Health Canada Drug Product Database under DIN 02494175, held by GALDERMA CANADA INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 28-Nov-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is AKLIEF used for?
Topical treatment of acne vulgaris of the face and/or trunk in patients 12 years of age and older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02494175 |
|---|---|
| Brand name | AKLIEF |
| Generic / active ingredient | TRIFAROTENE : 50 MCG |
| Manufacturer | GALDERMA CANADA INC |
| Strength | 50 MCG |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D10AD06 TRIFAROTENE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 28-Nov-2019 |
How is it administered?
Apply a thin layer to affected areas of face and/or trunk once daily in the evening on clean, dry skin. Wash hands after application. Use of moisturizer is recommended.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly stated in the provided text (section header exists but content is missing), though typically 15-30°C for such products.
How is it supplied?
2 g tube (sample); 15 g, 30 g, 45 g, and 75 g airless pump bottles.
Contraindications
Hypersensitivity to drug or ingredients; patients with eczema or seborrheic dermatitis; pregnancy; women planning a pregnancy.
Warnings and precautions
For external use only. Avoid contact with eyes/lips. Avoid excessive sunlight/UV exposure. May cause local cutaneous reactions (erythema, dryness). Avoid "waxing" on treated skin.
Who else supplies TRIFAROTENE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRIFAROTENE appears in 7 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.